{"name":"Shanghai Hansoh Biomedical Co., Ltd","slug":"shanghai-hansoh-biomedical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOSGZFczVxV3p5SGpVT3lwOFpJSjlyQlNjMU1CWm52SDFKTGdQakp6VjBVVndQcTdsZ1puOU1ueEhWTXFTZV9pSXBhZnlqb1RTV05vX1hXenBxWU95T1lMRkNlN0xOT1JoT0doWGF5VDE5eDh2SlJZWFdEakFMd2g2WHRacVNLYW9CbmFjVllMZXRxYmZzbjhXaEl6Q0lkeUpSdzFSOUNYc3E5SUVGRk5TX2hMQ0I1bUFYdzJXMWxjeS1qWGYxTjlxQUpxUW5tQQ?oc=5","date":"2026-01-22","type":"deal","source":"Investing.com","summary":"Terns Pharmaceuticals amends license agreement with Hansoh for TERN-701 rights - Investing.com","headline":"Terns Pharmaceuticals amends license agreement with Hansoh for TERN-701 rights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOVXJkX1pQaFpRdjdCR29vdS0wb3ZERDczVXo4Z0JFaDBrU3FET0NMUzlTQ08tVURIRk54Uk9KLUxwcnZiMVlSRmZsR1dYTi01V2IxUzJUcHo5WWdwOXZUMW1zTmZ1SW9SeXU2MlotRTRHcXViVlpoR0M5dExNeloxWlh5MmxGMnNQSlUzeXRPWmZBZVgxdjdVR3dmWEE5QnEwWXZSOVpUNnB2SmNzZkhNODk5RG9WZFRXWE5fbTNZQm5BV25DZk95WDBlUm9Ea1FhemVoRHRfNW1vbElZcEE?oc=5","date":"2025-10-17","type":"deal","source":"Reuters","summary":"China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche - Reuters","headline":"China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNUnl2bEw4NEpoSnVqMlFSbkFuSkN3OHp6VzhHMWZ4NzhuMVBzZHIxbm9SRVlmeEw3OUp6SklTU1MzTkJzNXdFNlFZUEZ3X0dSNGl5bkRzZUZnVGljNlRPYjdsY3FGT0RTMW9CVWhsNURzYUp6VjVJajlKUDM0QV9qYkt2aUdiM1VlNTVEcm14cjBPVnF6R1dobDJWYU8xQm5iRmFPS25JNWRhRlNKaVBNemlWbUJVOWxMNU1yQTln0gG-AUFVX3lxTE5WUTM4bU51MDdFUUM5emptLTlCeUxvV3hYZjNmdktEdkVDU2czNk84VnBsc08tOFZWcVp3a0w5anlIT1kxTXctRW14MEtmeWY5R3FoQkJqY1pBcnJhRVJuQlVtcmxPZ21HdkNWdXA5c3dXU2hLQlQ4X2g3UkJVZHFwXzlHSHdHVW9USHhoVmpRN0cybGxDaXdIQkN6bWpqczNBdFk1SkFZcm5sMktZQ1NVODVWOGJzSmZmMTJlSFE?oc=5","date":"2025-08-18","type":"earnings","source":"South China Morning Post","summary":"Chinese pharma firms Hengrui, Hansoh expected to post strong first-half profits - South China Morning Post","headline":"Chinese pharma firms Hengrui, Hansoh expected to post strong first-half profits","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxOYXM2QTdfbmJwVURFUnBPWXp0REUyblpQNXVXQ1NrY2IwVjdlQzFGaGhmcmZiclZoU0RBQzU0YV9UNmltUVRMX0ZHMEFhU3FzemVjQ1FrcmZ6YllSdmpqM3ROa19fQU1HTzc3SHBBQmFNYXgwaEdPZUNSX3I3RHd0N040MHRiSG95THF6M2FtMDhwQUxSNHhWQWpJNDZvdW9tLU5fT2k3UmQ2MC1kYXZ4ZkVPcC1lMlhHWlhWaEtKOG9HYjFTeFJvdzk2djd1RjVTQUR3LU1sclEwSzJiYUFBN3F3aG1tbXkzckFiT2xzV2VfQjJEY2tNRy02dEp3elFYQmg5Njk0ZThfMEs4eEhYaDhXMFRqVWd2VXdjMXZER0JQVXVVY0VrNGpn?oc=5","date":"2025-07-30","type":"pipeline","source":"PR Newswire","summary":"Osteosarcoma Market on the Rise in the 7MM During the Forecast Period (2025-2034) with Novel Therapeutics and Technological Innovations | DelveInsight - PR Newswire","headline":"Osteosarcoma Market on the Rise in the 7MM During the Forecast Period (2025-2034) with Novel Therapeutics and Technologi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQMzVKMHBnQUdEbGlDWnhudTN3WW1VNEluNE5ZRUs2MmZaaDFzUHE4UGcyM0QzRXFINGxfR1hydU9pdko4aE5UNkhNWFJYTDJrVDYyMjBENENCZlUzTGQwYzFYRWIyclJzdHg4Qy1ZVTZROTk1WTZyamxFM3JrbzlzR2xVYjg0YmtacTBMOHZHWjJwLVp0dUhIS2hPc21IVjJKNVJfRVRRZw?oc=5","date":"2025-06-03","type":"pipeline","source":"BioWorld News","summary":"Regeneron boosts obesity pipeline with Hansoh’s GLP-1/GIP for $2B - BioWorld News","headline":"Regeneron boosts obesity pipeline with Hansoh’s GLP-1/GIP for $2B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxOdVlhOFhDYnpBRGh4WlhFWG93ZHdmak5FZDVRVC1qWER1YlFhbnQ5TThBM0Y5ZjJaaExucGI2LVNsSmRUMDQ3cVBHT211N1JHVXNBRklDUTR1VjdITWkxSTA5OXNTMkZ2S3hnVDBMNHJYamp2Ri1UcHhBRlBLUWNxLXFMeHRlXzFpOXpkRzF4NlZWYlBGS0xqaGlHSlMzMkRFcG1tRjd4aU5sOE5TUWJvdklNd0F5YmZIMU91Tng5X0F3UlJESVI1M0tDaUFid2c1MjlhMlFiTHNGaUViTkN3b01pM2J4cndGY0NueG9VTTl0bGtmWF9KcEpZOVlodHZQWE5FbW1aNDBzTTNZTVNWTWpWZjhVM00zcHZIUV9sTQ?oc=5","date":"2025-01-14","type":"trial","source":"PR Newswire","summary":"Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Development | DelveInsight - PR Newswire","headline":"Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Develop","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNQ1B2a3ZQVHB2TmpCUEJxeHBvQjhJWmZ5N1V0dUZBclJTSDNzc3VwZ0VTeTI5cEtJTkd1Uk1fVE1wdENQdXZ1X3FXSGFGLWpvTWVHTmFTMjJFN3gzaE0xajhPbW5iS3pRMUdjVnJJa296Vjc3LWRCaGNUQVQ0WVk3VVVQamxRZ204anc?oc=5","date":"2024-08-30","type":"patent","source":"BioWorld News","summary":"Hansoh Pharma patents new GLP-1R agonists - BioWorld News","headline":"Hansoh Pharma patents new GLP-1R agonists","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQeDc5SWQ5U0dCSXpRdVdkVUdXYXl4V1BoT2FOVllqZG9YcXA4a1RDYndodDVBZ2c0ZmJxQWY2Y0xpaXZockw0Y3dES3NKTkx6LWltbDBZY3g1RGJmUVdjRHlLNnF1NDdXLVU3cXFJUXAySTJ2d3Uwd09ONGNBOVhiWkU0OHZKT3JmNHRHYW1jME5ScDlNai14VktjUjF5T3BFOGpRbGZZOXNGVDRsMHZNNg?oc=5","date":"2023-12-20","type":"deal","source":"GSK","summary":"GSK enters exclusive license agreement with Hansoh for HS-20093 - GSK","headline":"GSK enters exclusive license agreement with Hansoh for HS-20093","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNV2V1aFU3cFY5cUQ2MWkyX1N0VnMtTkdfMWJCelFRZUtDcndmS3JiejMxM29LNmtpbE9SX2pNYVl4bW45aFBYUlRaS1VPZTJaeFJabTNvZU9aQVY0QjBoenRDaWlvWnZaZGtkU21QQTVFT2RjRjk0RVUyanFZa1FZei02UDRHa2c5T185MEt6cVdGcko2OERHVGp2TURlXzA0NDhPa1Z0UDFYdW93TjRtS3VReDhaVWM3aEdtVmN6WWlaTzN2cmdOSVdaUFdfTGpfWmR3Q0g3S0FCZV9IMXdxY21TR055eDRmYU1kRi01QzcyUWpRMW5rS3Fpc0tJdlU?oc=5","date":"2020-07-23","type":"deal","source":"Business Wire","summary":"CORRECTING and REPLACING Hansoh Pharma Announces Strategic Collaboration and Licensing Agreement for Almonertinib - Business Wire","headline":"CORRECTING and REPLACING Hansoh Pharma Announces Strategic Collaboration and Licensing Agreement for Almonertinib","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}